Publication | Open Access
Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer
33
Citations
30
References
2022
Year
OncologyMedicinePharmacologyRos-ampk ActivationLiver CancerCancer TreatmentTumor SuppressorAntitumour ActivityCancer BiologyCell BiologyAnti-cancer AgentCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1